Alpa Laboratories Ltd Share Price Today - Alpa Laboratories Ltd Stock Price Live NSE/BSE

Alpa Laboratories Ltd

NSE: ALPA BSE: 532878

₹66.18

(0.90%)

Fri, 01 May 2026, 03:49 pm

MTF 5xInvest in Alpa Laboratories Ltd with 5x Leverage Buy with MTF

Market Cap1.41B

PE Ratio11.94

Dividend0

24.5K

Alpa Laboratories Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
136.78
Net Profit
19.50
P/B
1.28
Sector P/E
33.42
P/E
11.23
EV/EBITDA
7.72
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
9.69
ROCE (Industry)
13.46
RONW (Industry)
12.65
ROE
12.06
ROCE
15.76
Debt/Equity
0.02
EPS (TTM)
5.54
Dividend Yield
0
Book Value
87.12
Interest Cover
112.57

Analysis

all

Pros

Alpa Laboratories is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Alpa Laboratories is profitable, therefore cash runway is not a concern.
Alpa Laboratories is profitable, therefore cash runway is not a concern.
Debt is covered by short term assets, assets are 310.1x debt.
Alpa Laboratories's cash and other short term assets cover its long term commitments.

Cons

Unable to evaluate Alpa Laboratories's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Alpa Laboratories's dividend against the top 25% market benchmark as the company has not reported any payouts.
Operating cash flow is negative therefore debt is not well covered.
Paresh's remuneration is higher than average for companies of similar size in India.
Alpa Laboratories is not covered by any analysts.

Financials

Ratios

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	57.19	57.29	57.29	57.29	57.29
FII	0.38	0.36	0.35	0.36	0.40
DII	0	0	0	0	0
Public	42.43	42.35	42.35	42.34	42.31
Government	0	0	0	0	0

Technical Analysis

RSI

51.33

MACD

1.37

50 DMA

63.97

200 DMA

80.84

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	94.52	73.82	60.14	53.12	39.44	32.42	11.72
Fibonacci	73.82	65.91	61.03	53.12	45.21	40.33	32.42
Camarilla	52.15	50.26	48.36	53.12	44.56	42.66	40.77

Pivots Level: Classic

+41.40

94.52

+20.70

73.82

+7.02

60.14

53.12

Pivot Point

LTP: 66.18

-13.68

39.44

-20.70

32.42

-41.40

11.72

Moving Average

SMAEMA

Period

Value

10-EMA
67.24
20-EMA
66.16
30-EMA
65.52
50-EMA
65.83
100-EMA
69.82
200-EMA
78.16

Announcement Date	Purpose	Action	Ex Date
11 Feb 2026	board-meetings	Quarterly Results
14 Nov 2025	board-meetings	Quarterly Results
12 Sept 2025	agm
18 Sept 2024	agm
20 Aug 2024	agm	Annual General Meeting	21 Sept 2024
05 Sept 2023	agm
21 Aug 2023	agm	Annual General Meeting	22 Sept 2023
14 Sept 2022	agm
20 Aug 2022	agm	Annual General Meeting	22 Sept 2022
07 Sept 2021	agm

Alpa Laboratories Ltd

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd

Cipla Ltd

Alpa Laboratories Ltd About

Alpa Laboratories primary business lies in the manufacture and sale of Drugs and Chemicals.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1988

Headquarters

CEO

Mahendra Singh Chawla

Employees

Contact

Website

http://www.alpalabs.in

mail@alpalabs.in

Phone

91-731-4294567

Location

33/2 Pigdamber, A B Road Rau, Indore, Madhya Pradesh, 453446

Year	History
2006	Started participation in international tenders for export. Won a major tender from CMS, Sudan. Launched Veterinary Division with a new face and ethical promotion of its Veterinary products in 5 states. Launched Ethical division for its human products.
2007	Alpa Laboratories tied up with Vhermann Pharmaceutical Inc, Philippines for distribution of its products.
2010	The Company recommended a dividend of 10%.
2014	Ms. Monali Patel was appointed as the Company Secretary and Compliance Officer. Alpa Laboratories sold its Unit-II to Ipca Laboratories Limited on a slump sale basis.
2015	Alpa Laboratories Ltd formed a wholly owned subsidiary named Norfolk Mercantile Private Ltd.

Client Name	Order Side	QTY	Avg Price	Date
MICROCURVES TRADING PRIVATE LIMITED	Sell	122111	139.56	30 Sept 2024
HRTI PRIVATE LIMITED	Sell	138942	139.81	30 Sept 2024
HRTI PRIVATE LIMITED	Buy	155746	139.42	30 Sept 2024
NK SECURITIES RESEARCH PRIVATE LIMITED	Buy	183809	138.69	30 Sept 2024
QE SECURITIES LLP	Sell	200761	139.75	30 Sept 2024
QE SECURITIES LLP	Buy	203805	139.76	30 Sept 2024
MICROCURVES TRADING PRIVATE LIMITED	Buy	122111	139.54	30 Sept 2024
MUDUPULAVEMULA SURENDRANADHA REDDY	Buy	169278	139.21	30 Sept 2024
AAKRAYA RESEARCH LLP	Buy	246714	140.07	30 Sept 2024
AAKRAYA RESEARCH LLP	Sell	246714	140.23	30 Sept 2024

Alpa Laboratories Ltd News

Alpa Labs Appoints New Company Secretary & CO

Alpa Laboratories Ltd. announces the appointment of Ms. Yashoda Patidar as Company Secretary and Compliance Officer effective April 11, 2026, following board approval based on committee recommendations.

11 Apr 2026

companies

Alpa Labs clarifies no price sensitive info

Alpa Laboratories responds to stock exchange inquiry about price movement, confirms no undisclosed material information or upcoming announcements affecting stock performance.

10 Apr 2026

companies

Alpa Labs Share Transfer via Gift Between Promoters

Alpa Laboratories reports inter se transfer of 21,940 shares (0.10%) from Bakulesh Chandulal Shah HUF to Vinit Shah as gift between immediate relatives on March 7, 2026.

09 Mar 2026

co actions results

Alpa Laboratories Company Secretary Resigns

Alpa Laboratories announces resignation of Company Secretary Ms. Srashiti Chopra effective March 25, 2026, citing personal reasons for departure from compliance role.

25 Feb 2026

stocks

Alpa Labs Q3FY26 Results: Revenue Up 13.5% YoY

Alpa Laboratories reported Q3FY26 revenue of Rs 2,967.12 lacs vs Rs 2,615.02 lacs YoY. Net profit declined to Rs 187.48 lacs from Rs 889.30 lacs in Q3FY25.

11 Feb 2026

co actions results

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800